NSG 552 - Psychopharmacology
Exam 3
Question:
naltrexone class
Answer:
Opioid receptor antagonist
Question:
Naltrexone can be used for
Answer:
both ETOH and opioid use disorders
Question:
What does naltrexone do
Answer:
o Reduces desire/cravings
o First line treatment
o Will precipitate withdrawal in patients with physical opioid dependence
,Question:
o First line treatment in maintaining abstinence after detox
o Used for relapse prevention (post detoxification)
Answer:
acamprosate
Question:
acamprosate can be used
Answer:
in liver disease- not metabolized by the liver (not impacted by ETOH use). o
Can be administered to patients with hepatitis, liver disease, and those who
continue drinking alcohol
Question:
acamprosate Contraindicated in
Answer:
severe renal disease
Question:
acamprosate helps with
Answer:
Decreasing cravings
,Question:
ETOH 2nd line treatment
Answer:
· disulfiram (Antabuse)
Question:
disulfiram (Antabuse) causes
Answer:
aversion reaction to ETOH (flushing, headaches, n/v, palpitation, SOB,
vertigo, hypotension)
Question:
disulfiram (Antabuse) Do not
Answer:
administer until the person has been alcohol free at least 12 hours
Question:
disulfiram (Antabuse) MOA
Answer:
o Blocks enzyme (aldehyde dehydrogenase) in the liver
, Question:
ETOH withdrawal- Benzos · To keep patient calm and lightly sedated
Answer:
lorazepam, diazepam, chlordiazepoxide-Librium
Question:
Benzos MOA
Answer:
Enhance the effects of GABA
Question:
Meds used in mild alcohol withdrawal
Answer:
Tegretol, Valproic or Gabapentin
Question:
ETHO meds for nutritional deficiencies
Answer:
Thiamine, folic acid, and multivitamin - "Banana bag
Exam 3
Question:
naltrexone class
Answer:
Opioid receptor antagonist
Question:
Naltrexone can be used for
Answer:
both ETOH and opioid use disorders
Question:
What does naltrexone do
Answer:
o Reduces desire/cravings
o First line treatment
o Will precipitate withdrawal in patients with physical opioid dependence
,Question:
o First line treatment in maintaining abstinence after detox
o Used for relapse prevention (post detoxification)
Answer:
acamprosate
Question:
acamprosate can be used
Answer:
in liver disease- not metabolized by the liver (not impacted by ETOH use). o
Can be administered to patients with hepatitis, liver disease, and those who
continue drinking alcohol
Question:
acamprosate Contraindicated in
Answer:
severe renal disease
Question:
acamprosate helps with
Answer:
Decreasing cravings
,Question:
ETOH 2nd line treatment
Answer:
· disulfiram (Antabuse)
Question:
disulfiram (Antabuse) causes
Answer:
aversion reaction to ETOH (flushing, headaches, n/v, palpitation, SOB,
vertigo, hypotension)
Question:
disulfiram (Antabuse) Do not
Answer:
administer until the person has been alcohol free at least 12 hours
Question:
disulfiram (Antabuse) MOA
Answer:
o Blocks enzyme (aldehyde dehydrogenase) in the liver
, Question:
ETOH withdrawal- Benzos · To keep patient calm and lightly sedated
Answer:
lorazepam, diazepam, chlordiazepoxide-Librium
Question:
Benzos MOA
Answer:
Enhance the effects of GABA
Question:
Meds used in mild alcohol withdrawal
Answer:
Tegretol, Valproic or Gabapentin
Question:
ETHO meds for nutritional deficiencies
Answer:
Thiamine, folic acid, and multivitamin - "Banana bag
